NPS RADAR provides health professionals with timely, independent evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme.

NPS RADAR is print-published three times a year, in line with major updates to the Schedule of Pharmaceutical Benefits, so it is available around the time when new medicines can be prescribed or dispensed.

Our free NPS RADAR email alerts keep subscribers up to date with new drugs and medical tests as each new issue of RADAR is released.

Latest issue

Editorial — Patient information on the RADAR

For selected NPS RADAR review topics NPS MedicineWise also produces Medicine Update – a consumer companion publication you can download for your patients.

Brief item: New metformin fixed-dose combinations PBS listed

Four new metformin/gliptin fixed-dose combinations for the treatment of type 2 diabetes are now available on the PBS.

Glycopyrronium (Seebri) for chronic obstructive pulmonary disease

Glycopyrronium (Seebri Breezhaler) is a PBS-listed, once-daily, inhaled, long-acting anticholinergic bronchodilator for maintenance treatment in chronic obstructive pulmonary disease.

Download issue